Evidence map›Paper›PMID 19666105›Full record

ArticleFree radical biology & medicine2009

Overexpression of Cu/Zn-superoxide dismutase and/or catalase accelerates benzo(a)pyrene detoxification by upregulation of the aryl hydrocarbon receptor in mouse endothelial cells.

Zefen Wang, Hong Yang, Aramandla Ramesh, L Jackson Roberts, Lichun Zhou, Xinhua Lin, Yanfeng Zhao, Zhongmao Guo

Open access · greenAbstract read
In one paragraph

Article in Free radical biology & medicine, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.8field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 34 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Comparative evaluation of different cell lysis and extraction methods for studying benzo(a)pyrene metabolism in HT-29 colon cancer cell cultures.Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology · 2011
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Zefen WangDepartment of Cardiovascular Biology, Meharry Medical College, Nashville, TN 37208, USA.
Hong Yang
Aramandla Ramesh
L Jackson Roberts
Lichun Zhou
Xinhua Lin
Yanfeng Zhao
Zhongmao Guo
Meharry Medical College · USVanderbilt University · US

Funding

VITAMIN D DEFICIENCY AND INCREASED RISK OF UTERINE FIBROIDS IN AFRICAN AMERICANSG12RR003032 · NCRR · MEHARRY MEDICAL COLLEGE · PI RILEY, WAYNE JOSEPH · 1985 to 2011
$27.4M
RESEARCH PROJECT: "Mechanisms of B(a)P Induced Neurotoxicity"S11ES014156 · NIEHS · MEHARRY MEDICAL COLLEGE · PI HOOD, DARRYL BRICE · 2006 to 2010
$3.8M
Effect of antioxidant enzymes on BaP-induced atherogenesisR01ES014472 · NIEHS · MEHARRY MEDICAL COLLEGE · PI GUO, ZHONGMAO · 2007 to 2010
$1.3M
The Role of Oxidative Stress in Endothelial AgingK01HL076623 · NHLBI · MEHARRY MEDICAL COLLEGE · PI YANG, HONG · 2004 to 2008
$788k
Chemoprevention of colon cancer via neonatal imprintingR03CA130112 · NCI · MEHARRY MEDICAL COLLEGE · PI RAMESH, ARAMANDLA · 2007 to 2008
$147k
NCI NIH HHS R03 CA130112NCI NIH HHS R03CA130112-01NCRR NIH HHS G12 RR003032NCRR NIH HHS G12RR003032NCRR NIH HHS G12RR03032NHLBI NIH HHS K01 HL076623NHLBI NIH HHS K01HL-076623NIEHS NIH HHS R01ES014471NIEHS NIH HHS R01 ES014472NIEHS NIH HHS S11 ES014156NIEHS NIH HHS S11ES014156-02
6 · The paper itself

Abstract

A reduction in endogenously generated reactive oxygen species in vivo delays benzo(a)pyrene (BaP)-accelerated atherosclerosis, as revealed in hypercholesterolemic mice overexpressing Cu/Zn-superoxide dismutase (SOD) and/or catalase. To understand the molecular events involved in this protective action, we studied the effects of Cu/Zn-SOD and/or catalase overexpression on BaP detoxification and on aryl hydrocarbon receptor (AhR) expression and its target gene expression in mouse aortic endothelial cells (MAECs). Our data demonstrate that overexpression of Cu/Zn-SOD and/or catalase leads to an 18- to 20-fold increase in the expression of AhR protein in MAECs. After BaP exposure, the amount of AhR binding to the cytochrome P450 (CYP) 1A1 promoter was significantly greater, and the concentrations of BaP reactive intermediates were significantly less in MAECs overexpressing Cu/Zn-SOD and/or catalase than in wild-type cells. In addition, the BaP-induced CYP1A1 and 1B1 protein levels and BaP-elevated glutathione S-transferase (GST) activity were significantly higher in these transgenic cells, in parallel with elevated GSTp1, CYP1A1, and CYP1B1 mRNA levels, compared to wild-type MAECs. Moreover, knockdown of AhR with RNA interference diminished the Cu/Zn-SOD and catalase enhancement of CYP1A1 expression, GST activity, and BaP detoxification. These data demonstrate that overexpression of Cu/Zn-SOD and/or catalase is associated with upregulation of AhR and its target genes, such as xenobiotic-metabolizing enzymes.

Indexed as

AnimalsAortaAryl Hydrocarbon HydroxylasesBenzo(a)pyreneBlotting, WesternCatalaseCells, CulturedCytochrome P-450 CYP1A1Cytochrome P-450 CYP1B1Endothelium, VascularF2-IsoprostanesFuransGlutathione TransferaseInactivation, MetabolicMiceReceptors, Aryl HydrocarbonAryl Hydrocarbon HydroxylasesBenzo(a)pyreneCatalaseCyp1b1 protein, mouseCytochrome P-450 CYP1A1Cytochrome P-450 CYP1B1F2-IsoprostanesFuransGlutathione TransferaseReceptors, Aryl HydrocarbonRNA, MessengerRNA, Small InterferingSuperoxide Dismutase

Identifiers

PMID19666105
PMCPMC2846758
OpenAlexW2029234230

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.